Chongqing, China

Ning Wang

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 9.3

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Ning Wang in Sepsis Treatment

Introduction

Ning Wang is an accomplished inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of sepsis and autoimmune diseases. With a total of 2 patents, his work focuses on utilizing traditional Chinese medicine to develop effective drug formulations.

Latest Patents

Ning Wang's latest patents include the use of Kukoamine A and Kukoamine B. This patent discloses the application of these compounds in preparing drugs aimed at preventing and treating sepsis and autoimmune diseases. The invention specifically targets bacterial endotoxin/lipopolysaccharide (LPS) and unmethylated DNA (CpG DNA), which are major pathogen-associated molecular patterns in these conditions. By isolating lead compounds from traditional Chinese medicine, Wang's approach addresses the uncertainties surrounding the pharmacological material basis and drug targets of herbal extracts. This innovation aims to develop safe, effective, and quality-controllable drugs to fill the current gap in clinical treatment options.

Another significant patent involves the salts of Kukoamine B, detailing their preparation method and pharmaceutical use. Experimental results indicate that these salts effectively antagonize key factors inducing sepsis. The medicinal formulations comprising salts of Kukoamine B, along with pharmaceutically acceptable carriers and/or diluents, present a novel approach for preventing and treating sepsis, especially in light of the current lack of effective clinical measures.

Career Highlights

Ning Wang has worked with notable organizations, including Tianjin Chase Sun Pharmaceutical Co., Ltd and The First Affiliated Hospital, Third Military Medical University. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Ning Wang has collaborated with several professionals in his field, including Jiang Zheng and Xin Liu. These partnerships have enhanced his research efforts and broadened the impact of his innovations.

Conclusion

Ning Wang's contributions to the pharmaceutical industry, particularly in the treatment of sepsis and autoimmune diseases, highlight the potential of traditional Chinese medicine in modern drug development. His innovative patents pave the way for new therapeutic options that could significantly improve clinical outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…